Dexcom (DXCM) Raw Materials (2010 - 2026)

Dexcom (DXCM) has 13 years of Raw Materials data on file, last reported at $247.9 million in Q1 2026.

• Raw Materials for Q1 2026 came in at $247.9 million, down 32.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $247.9 million (down 32.27% YoY), and the FY2025 annual result was $257.6 million, down 21.25% from the prior year.
• Raw Materials slipped to $247.9 million in Q1 2026 per DXCM's latest filing, from $257.6 million in the prior quarter.
• Over five years, Raw Materials peaked at $366.0 million in Q1 2025 and troughed at $151.1 million in Q2 2022.
• A 5-year average of $254.0 million and a median of $257.6 million in 2025 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2023 and 2026: Raw Materials soared 100.94% in 2023, then slumped 32.27% in 2026.
• A 5-year view of Raw Materials shows it stood at $159.0 million in 2022, then soared by 100.94% to $319.5 million in 2023, then gained by 2.38% to $327.1 million in 2024, then slipped by 21.25% to $257.6 million in 2025, then decreased by 3.77% to $247.9 million in 2026.
• Business Quant data shows DXCM's Raw Materials at $247.9 million in Q1 2026, $257.6 million in Q4 2025, and $266.0 million in Q3 2025.